Pricing Log in Create free account

QIAGEN N.V. (QGEN) vs RadNet, Inc. (RDNT)

QIAGEN N.V. and RadNet, Inc. are both Diagnostics & Research companies. QIAGEN N.V. is the larger, with a market value of $9.5B against $5.5B — 1.7× the size. RadNet, Inc. has negative trailing earnings, so its P/E is not meaningful; QIAGEN N.V. trades at 23.6×. RadNet, Inc. grew revenue faster over the last twelve months: 18.9% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs −0.93%) and the higher return on invested capital (6.62% vs 2.24%). Across the 21 metrics below, QIAGEN N.V. leads on 17 and RadNet, Inc. on 4.

Valuation

Metric QGEN RDNT Diagnostics & Research median
P/E 23.64 n/m 35.56
P/S 4.53 2.35 4.37
P/B 2.83 3.82 3.06
Price to free cash flow 21.60 164.99 35.76
EV/EBITDA 15.93 19.29 24.35
EV/Sales 4.94 2.62 5.51
Earnings yield 4.23% (0.39%) (1.89%)
Free cash flow yield 4.63% 0.61% (0.15%)

Profitability

Metric QGEN RDNT Diagnostics & Research median
Gross margin 62.20% 11.53% 50.89%
Operating margin 21.21% 3.12% (8.57%)
Net margin 19.49% (0.93%) (6.37%)
Free cash flow margin 20.98% 3.28% 0.00%
Return on equity 11.93% (1.64%) (2.92%)
Return on assets 6.99% (0.55%) (6.71%)
Return on invested capital 6.62% 2.24% 0.00%

Growth

Metric QGEN RDNT Diagnostics & Research median
Revenue growth (TTM) 2.96% 18.92% 7.69%
EPS growth (last fiscal year) 398.07% (725.00%) 25.92%
Revenue growth, 5-year CAGR 2.25% 13.74% 7.40%
Net income growth, 5-year CAGR 3.42% 0.00% 0.00%

Health

Metric QGEN RDNT Diagnostics & Research median
Debt to equity 0.49 0.94 0.11
Current ratio 2.85 1.48 2.02
Net debt to EBITDA 0.84 1.16 0.70

Dividend

Metric QGEN RDNT Diagnostics & Research median
Dividend yield 0.76% — 0.66%
Payout ratio 0.18 — 0.20

Size

Metric QGEN RDNT Diagnostics & Research median
Market cap 9.51b 5.54b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack